BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2953336)

  • 1. Peptidyl fluoromethyl ketones as thiol protease inhibitors.
    Shaw E; Angliker H; Rauber P; Walker B; Wikstrom P
    Biomed Biochim Acta; 1986; 45(11-12):1397-403. PubMed ID: 2953336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
    Wikstrom P; Kirschke H; Stone S; Shaw E
    Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of time-dependent inactivation of human tumor cathepsin B isozymes by a peptidyl fluoromethyl ketone using a fluorescent print technique.
    Smith RE; Rasnick D; Burdick CO; Cho KJ; Rose JC; Vahratian A
    Anticancer Res; 1988; 8(4):525-9. PubMed ID: 3178145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of cathepsin B.
    Shaw E; Kettner C
    Acta Biol Med Ger; 1981; 40(10-11):1503-11. PubMed ID: 7342602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of peptidylfluoromethanes and their properties as inhibitors of serine proteinases and cysteine proteinases.
    Rauber P; Angliker H; Walker B; Shaw E
    Biochem J; 1986 Nov; 239(3):633-40. PubMed ID: 3827817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of serine proteases by peptidyl fluoromethyl ketones.
    Imperiali B; Abeles RH
    Biochemistry; 1986 Jul; 25(13):3760-7. PubMed ID: 3527255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G.
    Peet NP; Burkhart JP; Angelastro MR; Giroux EL; Mehdi S; Bey P; Kolb M; Neises B; Schirlin D
    J Med Chem; 1990 Jan; 33(1):394-407. PubMed ID: 2296031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidyl Fluoromethyl Ketones and Their Applications in Medicinal Chemistry.
    Citarella A; Micale N
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32899354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thermitase--a thermostable serine protease. IV. Kinetic studies on the binding of N-acyl peptide ketones as substrate analog inhibitors].
    Fittkau S; Smalla K; Pauli D
    Biomed Biochim Acta; 1984; 43(7):887-99. PubMed ID: 6393957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
    Hughes FM; Evans-Storms RB; Cidlowski JA
    Cell Death Differ; 1998 Dec; 5(12):1017-27. PubMed ID: 9894608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodination of peptidyl chloromethyl ketones for protease affinity labels.
    Rauber P; Wikstrom P; Shaw E
    Anal Biochem; 1988 Feb; 168(2):259-64. PubMed ID: 3163239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of lysylfluoromethanes and their properties as inhibitors of trypsin, plasmin and cathepsin B.
    Angliker H; Wikstrom P; Rauber P; Shaw E
    Biochem J; 1987 Feb; 241(3):871-5. PubMed ID: 2954536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dirofilaria immitis: effect of fluoromethyl ketone cysteine protease inhibitors on the third- to fourth-stage molt.
    Richer JK; Hunt WG; Sakanari JA; Grieve RB
    Exp Parasitol; 1993 May; 76(3):221-31. PubMed ID: 8500582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of histidine-containing dipeptide affinity-labelling agents. Relative inactivation rates of cathepsins B and L.
    Angliker H; Zumbrunn A; Shaw E
    Int J Pept Protein Res; 1991 Oct; 38(4):346-9. PubMed ID: 1797709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
    Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
    Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Synthetic Routes to Peptidyl Mono-Fluoromethyl Ketones (FMKs) and Their Applications.
    Lloyd CM; Colgin N; Cobb SL
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33260551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones.
    Niestroj AJ; Feussner K; Heiser U; Dando PM; Barrett A; Gerhartz B; Demuth HU
    Biol Chem; 2002; 383(7-8):1205-14. PubMed ID: 12437107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis.
    Esser RE; Watts LM; Angelo RA; Thornburg LP; Prior JJ; Palmer JT
    J Rheumatol; 1993 Jul; 20(7):1176-83. PubMed ID: 8371213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of peptide inhibitors of blood coagulations.
    Bajusz S; Széll E; Barabás E; Bagdy D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):16-21. PubMed ID: 6177598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl sulfonium salts. A new class of protease inhibitors.
    Shaw E
    J Biol Chem; 1988 Feb; 263(6):2768-72. PubMed ID: 3343231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.